![](/img/cover-not-exists.png)
The Efficacy and Safety of Panitumumab Administered Concomitantly With FOLFIRI or Irinotecan in Second-Line Therapy for Metastatic Colorectal Cancer: The Secondary Analysis From STEPP (Skin Toxicity Evaluation Protocol With Panitumumab) by KRAS Status
Edith P. Mitchell, Bilal Piperdi, Mario E. Lacouture, Heather Shearer, Nicholas Iannotti, Madhavan V. Pillai, Feng Xu, Mohamed YassineVolume:
10
Year:
2011
Language:
english
Pages:
340
DOI:
10.1016/j.clcc.2011.06.004
File:
PDF, 356 KB
english, 2011